3 Huge Biotech Winners in 2018 (So Far)

Biotech investing isn't for the faint of heart. Clinical trial successes or failures can cause stocks to pop or drop by eye-popping amounts. For instance, Arrowhead Pharmaceuticals(NASDAQ:ARWR), Endocyte Inc. (NASDAQ:ECYT), and Madrigal Pharmaceuticals(NASDAQ:MDGL) are up a whopping 346%, 285%, and 227%, respectively, so far in 2018. Read on to learn why these stocks are skyrocketing this year and if there's still room to climb.